biotech
Jennifer Lawrence to Star in Theranos Movie
Jennifer Lawrence to Star in Theranos Movie
Tanya Lewis | Jun 13, 2016
The actress will portray the troubled blood testing startup’s founder, Elizabeth Holmes. 
$1.5 Billion Pharma Buyout for Leukemia Drug
$1.5 Billion Pharma Buyout for Leukemia Drug
Jef Akst | Jun 1, 2016
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.
Biotech Sponsors Science Competition
Biotech Sponsors Science Competition
Tanya Lewis | May 26, 2016
Regeneron Pharmaceuticals takes over from Intel as the sponsor of the Science Talent Search.
Report: Still Lots to Learn About GE Crops
Report: Still Lots to Learn About GE Crops
Tracy Vence | May 17, 2016
A National Academies–led analysis evaluates the impacts of genetically engineered crops—and calls for updated regulations.
Another Gene-Editing IPO
Another Gene-Editing IPO
Bob Grant | Apr 12, 2016
Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.
Inaccurate Cholesterol Tests from Theranos
Inaccurate Cholesterol Tests from Theranos
Jef Akst | Mar 29, 2016
The company’s finger-prick tests yield cholesterol levels notably lower than results of traditional blood draw tests from two other large companies, according to a study.
Science Exchange Raises $25M
Science Exchange Raises $25M
Kerry Grens | Mar 24, 2016
With fresh funding, the experiment-services and independent-validation startup will expand its staff.
Cannabis-Based Drug for Epilepsy
Cannabis-Based Drug for Epilepsy
Jef Akst | Mar 14, 2016
A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 
TS Picks: December 30, 2015
TS Picks: December 30, 2015
Kerry Grens | Dec 30, 2015
Overvaluing startups; undervaluing human research participants; curing aging?
Following FDA OK, 23andMe to Expand Health Prediction
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015
The personal genomics firm is ramping up its suite of disease-related genetic tests.